Affiliation:
1. UNC Eshelman School of Pharmacy
2. Boston University School of Medicine, Fruit of Labor Action Research & Technical Assistance
Abstract
Abstract
Background
Although fentanyl test strips (FTS) can accurately determine the presence of fentanyl in unregulated substances, access to FTS remains limited. This study aimed to examine North Carolina community pharmacists’ attitudes and willingness to engage in various behaviors related to FTS sales and distribution.
Methods
A convenience sample of community pharmacists completed an online survey that assessed: (1) comfort initiating a FTS conversation; (2) willingness to sell FTS, distribute FTS instructions, counsel on FTS, refer patients to harm reduction organizations, and advertise FTS; (3) perceived barriers and benefits of selling FTS; and (4) interest in FTS training. Data were collected from March to May 2022. Descriptive statistics were calculated.
Results
Of the 592 pharmacists who participated, most were somewhat or very willing to refer patients to harm reduction organizations for FTS (514, 86.9%), counsel on FTS (485, 81.9%), distribute FTS instructions (475, 80.2%), sell FTS (470, 79.3%), and advertise FTS for sale (372, 62.9%). The most commonly reported benefits of selling FTS was reducing overdose deaths in the community (n = 482, 81.4%) and participating in community harm reduction efforts (n = 455; 76.9%). Barriers commonly reported to selling FTS were: not knowing where to order FTS (n = 295, 49.8%) and discomfort initiating a conversation about FTS (n = 266, 44.9%). Most respondents (88.3%) were interested in FTS training.
Conclusion
North Carolina community pharmacists are willing to engage in various behaviors related to FTS sales and distribution. Pharmacists may benefit from FTS training that focuses on barriers to FTS sales. Pharmacist distribution of FTS could increase access to FTS at the community level, and has the potential to change drug use behavior and reduce overdose deaths.
Publisher
Research Square Platform LLC
Reference24 articles.
1. U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020 - But Are Still Up 15%. Published May 11, 2022. Accessed May 30, 2022. http://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm
2. FACT SHEET: White House Releases 2022 National Drug Control Strategy that Outlines Comprehensive Path Forward to Address Addiction and the Overdose Epidemic. The White House. Published April 21, 2022. Accessed May 30, 2022. https://www.whitehouse.gov/briefing-room/statements-releases/2022/04/21/fact-sheet-white-house-releases-2022-national-drug-control-strategy-that-outlines-comprehensive-path-forward-to-address-addiction-and-the-overdose-epidemic/
3. Abuse NI on D. Fentanyl DrugFacts. National Institute on Drug Abuse. Published June 1, 2021. Accessed June 16, 2022. https://nida.nih.gov/publications/drugfacts/fentanyl
4. NC Office of the Chief Medical Examiner. OCME-Fentanyl-PositiveDeathsApr2022. Published online May 13, 2022. https://injuryfreenc.dph.ncdhhs.gov/DataSurveillance/StatewideOverdoseSurveillanceReports/OpioidOverdoseEDVisitsMonthlyReports/OCME-Fentanyl-PositiveDeathsApr2022.pdf
5. A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study;Park JN;Addict Behav,2020